Suppr超能文献

系统性红斑狼疮T细胞中Syk的差异表达及分子关联

Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.

作者信息

Krishnan Sandeep, Juang Yuang-Taung, Chowdhury Bhabadeb, Magilavy Abigail, Fisher Carolyn U, Nguyen Hang, Nambiar Madhusoodana P, Kyttaris Vasileios, Weinstein Arthur, Bahjat Rena, Pine Polly, Rus Violeta, Tsokos George C

机构信息

Department of Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

出版信息

J Immunol. 2008 Dec 1;181(11):8145-52. doi: 10.4049/jimmunol.181.11.8145.

Abstract

Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this "rewired TCR" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.

摘要

TCRζ链表达减少以及FcRγ与TCR/CD3复合物相互上调并结合,是系统性红斑狼疮(SLE)T细胞的一个特征。在本研究中,我们探讨了优先与FcRγ结合的脾酪氨酸激酶Syk的不同分子结合是否导致SLE中这种“重新布线的TCR”下游信号的病理性放大。与正常T细胞相比,我们在SLE中检测到更高水平的Syk表达和活性。选择性抑制Syk的活性降低了TCR诱导的钙反应强度,并仅在SLE T细胞中减缓了肌动蛋白聚合的快速动力学。Syk和ZAP-70与SLE T细胞中参与细胞骨架和钙信号传导的关键分子的结合方式也有所不同。因此,虽然Vav-1和LAT优先与Syk结合,但磷脂酶C-γ1与Syk和ZAP-70都结合。我们的结果表明,Syk家族激酶的不同结合导致SLE T细胞中TCR诱导的信号反应增强。因此,我们建议将Syk作为控制SLE中异常T细胞反应的一种分子靶向措施。

相似文献

1
Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.
J Immunol. 2008 Dec 1;181(11):8145-52. doi: 10.4049/jimmunol.181.11.8145.
2
Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase.
Mol Cell Biol. 1997 Aug;17(8):4434-41. doi: 10.1128/MCB.17.8.4434.
4
c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells.
J Biol Chem. 2012 Apr 6;287(15):11833-41. doi: 10.1074/jbc.M111.333997. Epub 2012 Feb 21.
7
Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells.
Clin Exp Immunol. 2012 Feb;167(2):235-45. doi: 10.1111/j.1365-2249.2011.04505.x.
8
T-cell receptor-induced phosphorylation of the zeta chain is efficiently promoted by ZAP-70 but not Syk.
Blood. 2004 Aug 1;104(3):760-7. doi: 10.1182/blood-2003-12-4314. Epub 2004 Apr 1.
10
Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
J Exp Med. 1995 Jun 1;181(6):1997-2006. doi: 10.1084/jem.181.6.1997.

引用本文的文献

1
Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis.
Int J Mol Sci. 2024 Oct 10;25(20):10905. doi: 10.3390/ijms252010905.
3
Advances in natural products and antibody drugs for SLE: new therapeutic ideas.
Front Pharmacol. 2023 Jul 10;14:1235440. doi: 10.3389/fphar.2023.1235440. eCollection 2023.
5
New small molecules in dermatology: for the autoimmunity, inflammation and beyond.
Inflamm Res. 2023 Jun;72(6):1257-1274. doi: 10.1007/s00011-023-01744-w. Epub 2023 May 22.
6
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline.
Drugs. 2023 Apr;83(6):479-496. doi: 10.1007/s40265-023-01856-x. Epub 2023 Mar 27.
7
Aberrant B-Cell Activation in Systemic Lupus Erythematosus.
Kidney Dis (Basel). 2022 Oct 31;8(6):437-445. doi: 10.1159/000527213. eCollection 2022 Dec.
8
Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus.
Front Immunol. 2022 Oct 28;13:1007078. doi: 10.3389/fimmu.2022.1007078. eCollection 2022.
9
Recent advances in cutaneous lupus.
J Autoimmun. 2022 Oct;132:102865. doi: 10.1016/j.jaut.2022.102865. Epub 2022 Jul 17.

本文引用的文献

1
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
J Pharmacol Exp Ther. 2006 Dec;319(3):998-1008. doi: 10.1124/jpet.106.109058. Epub 2006 Aug 31.
2
FcR gamma presence in TCR complex of double-negative T cells is critical for their regulatory function.
J Immunol. 2006 Aug 15;177(4):2250-7. doi: 10.4049/jimmunol.177.4.2250.
3
Autoimmunity in systemic lupus erythematosus: integrating genes and biology.
Semin Immunol. 2006 Aug;18(4):230-43. doi: 10.1016/j.smim.2006.03.011. Epub 2006 May 19.
6
T cell rewiring in differentiation and disease.
J Immunol. 2003 Oct 1;171(7):3325-31. doi: 10.4049/jimmunol.171.7.3325.
8
Intrinsic T cell defects in systemic autoimmunity.
Ann N Y Acad Sci. 2003 Apr;987:60-7. doi: 10.1111/j.1749-6632.2003.tb06033.x.
10
Abnormal T cell signal transduction in systemic lupus erythematosus.
Arthritis Rheum. 2002 May;46(5):1139-54. doi: 10.1002/art.10192.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验